デフォルト表紙
市場調査レポート
商品コード
1747287

光線力学的療法市場:製品タイプ別、光源別、用途別、エンドユーザー別、地域別

Photodynamic Therapy Market, By Product Type, By Light Source, By Application, By End User, By Geography


出版日
ページ情報
英文 173 Pages
納期
2~3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.08円
光線力学的療法市場:製品タイプ別、光源別、用途別、エンドユーザー別、地域別
出版日: 2025年05月07日
発行: Coherent Market Insights
ページ情報: 英文 173 Pages
納期: 2~3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

光線力学的療法市場は、2025年には53億2,000万米ドルと推定され、2032年には94億8,000万米ドルに達すると予測され、2025年から2032年までのCAGRは8.6%を示します。

レポート範囲 レポート詳細
基準年 2024 2025年の市場規模 53億2,000万米ドル
実績データ 2020年から2024年まで 予測期間 2025年から2032年
予測期間:2025年~2032年 CAGR: 8.60% 2032年の価値予測 94億8,000万米ドル

光線力学的療法は、光に反応する薬剤と特殊な光源を用いて、がん細胞や前がん細胞を破壊します。この治療は、周囲の健康な組織へのダメージを制限します。治療部位に応じて、光増感剤を飲み薬、注射、点滴で投与します。その後、医師がその部位に特殊な光を照射します。

市場力学

がんや皮膚疾患の罹患率の増加、低侵襲治療の需要、技術の進歩が、予測期間における世界の光線力学的療法市場の成長を牽引すると予想されます。さらに、有利な規制当局の承認も、予測期間中の世界の光線力学的療法市場の成長を後押しすると予想されます。個別化された治療アプローチ、製薬会社との連携、画像技術の進歩、遠隔医療や遠隔診察は、予測期間中に世界の光線力学的療法市場に成長機会をもたらすと期待されています。

しかし、限られた認識と教育、高額な治療費、複雑な治療プロトコルが、予測期間中の光線力学的療法市場の成長を妨げると予想されます。

本調査の主な特徴

  • 世界の光線力学的療法市場を詳細に分析し、2024年を基準年とした予測期間(2025~2032年)の市場規模およびCAGRを掲載しています。
  • また、さまざまなセグメントにわたる潜在的な収益機会を明らかにし、この市場の魅力的な投資提案のマトリックスについて解説しています。
  • また、市場促進要因、抑制要因、機会、新製品の発売や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
  • 企業ハイライト、製品ポートフォリオ、主要なハイライト、財務実績、戦略などのパラメータに基づいて、世界の光線力学的療法市場の主要企業をプロファイルしています。
  • 本レポートの洞察により、マーケティング担当者や企業の経営陣は、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことができます。
  • この調査レポートは、光線力学的療法の世界市場を調査し、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界のさまざまな利害関係者に提供しています。
  • 利害関係者は、世界の光線力学的療法市場の分析に使用される様々な戦略マトリックスを通じて、意思決定が容易になります。

目次

第1章 調査の目的と前提条件

  • 調査目的
  • 前提条件
  • 略語

第2章 市場の展望

  • レポートの説明
    • 市場の定義と範囲
  • エグゼクティブサマリー
  • Coherent Opportunity Map(COM)

第3章 市場力学、規制、動向分析

  • 市場力学
    • 促進要因
  • がんや皮膚疾患の発生率の増加
  • 低侵襲治療の需要技術の進歩
    • 抑制要因
  • 高額な治療費
  • 複雑な治療プロトコル
    • 機会
  • 個別化された治療アプローチ
  • 製薬会社との連携
  • 画像技術の進歩
  • 影響分析
  • 主なハイライト
  • 規制シナリオ
  • 製品の発売/承認
  • PEST分析
  • PORTERの分析
  • 合併と買収のシナリオ

第4章 世界の光線力学的療法市場- コロナウイルス(COVID-19)パンデミックの影響

  • COVID-19疫学
  • 供給側と需要側の分析
  • 経済への影響

第5章 世界の光線力学的療法市場、製品タイプ別、2020年~2032年

  • 光感受性薬
  • ポルフィリン誘導体(PD)
  • ヘマトポルフィリン誘導体(HpD)
  • ベンゾポルフィリン誘導体(BPD)
  • テキサフィリン
  • その他
  • アミノレブリン酸(ALA)
  • クロリン
  • その他
  • 光線力学的療法装置
  • 使い捨て光ファイバー光伝送デバイス(DFOLDD)
  • ダイオードレーザー

第6章 世界の光線力学的療法市場、光源別、2020年~2032年

  • レーザー
  • 発光ダイオード(LED)
  • ランプ
  • その他

第7章 世界の光線力学的療法市場、用途別、2020年~2032年

  • がん
  • 日光角化症(AK)
  • 乾癬
  • ニキビ
  • その他

第8章 世界の光線力学的療法市場、エンドユーザー別、2020年~2032年

  • 病院
  • がん治療センター
  • 美容皮膚科クリニック
  • その他

第9章 世界の光線力学的療法市場、地域別、2020年~2032年

  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東
  • アフリカ

第10章 競合情勢

  • Gladerma S.A.
  • Sun Pharmaceutical Industries Ltd.
  • Biofrontera
  • Novartis AG
  • Valeant Pharmaceuticals International, Inc.
  • Quest Pharmatech, Inc.
  • Hologic, Inc.
  • Lumibird(Quantel Medical)
  • Theralase Technologies Inc.
  • Photocure ASA
  • Biolitec AG
  • IPG Photonics Corporation

第11章 セクション

  • 調査手法
  • 出版社について
目次
Product Code: CMI6148

Photodynamic Therapy Market is estimated to be valued at USD 5.32 Bn in 2025 and is expected to reach USD 9.48 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of 8.6% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 5.32 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 8.60% 2032 Value Projection: USD 9.48 Bn

Photodynamic therapy uses light-sensitive medicine and a special light source tdestroy cancerous or precancerous cells. This treatment limits damage tsurrounding healthy tissue. You'll receive the photosensitizer by mouth, injection or through an IV, depending on the area being treated. Then the doctor exposes the area tspecial light.

Market Dynamics

Increasing incidence of cancer and skin disorders, minimally invasive treatment demand, and advancements in technology is anticipated tdrive growth of the global photodynamic therapy market over the forecast period. Moreover, favorable regulatory approvals is alsexpected tboost the growth of the global photodynamic therapy market over the forecast period. Personalized treatment approaches, collaboration with pharmaceutical companies, advancements in imaging techniques, and telemedicine and remote consultations are expected tcreate growth opportunities for the global photodynamic therapy market during the forecast period.

However, limited awareness and education, high treatment costs, and complex treatment protocols are expected thamper growth of the photodynamic therapy market over the forecast period.

Key features of the study

  • This report provides in-depth analysis of the global photodynamic therapy market, and provides market size (US$ Billion) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study alsprovides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global photodynamic therapy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Biofrontera AG, Theralase Technologies Inc., Photocure ASA, Quest PharmaTech Inc., Galderma S.A., DUSA Pharmaceuticals (a subsidiary of Sun Pharmaceutical Industries), Lumenis Ltd. (acquired by Bausch Health Companies Inc.), Biolitec AG, IPG Photonics Corporation, Boston Scientific Corporation, Asieris Meditech Co., Ltd., PDT Pharmaceuticals, Inc., Candela Corporation (a subsidiary of Syneron Medical Ltd.), Biolase, Inc., Photothera (now known as EpiCept Corporation)
  • Insights from this report would allow marketers and the management authorities of the companies tmake informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global photodynamic therapy market report caters tvarious stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global photodynamic therapy market

Market Segmentation

  • Global Photodynamic Therapy market, By Indication
    • Cancer (Skin cancer, Lung cancer, Brain cancer, etc.)
    • Dermatological Conditions (Acne, Psoriasis, Actinic Keratosis, etc.)
    • Ophthalmology (Age-related Macular Degeneration, Retinal Diseases, etc.)
    • Infectious Diseases (Fungal Infections, Bacterial Infections, etc.)
  • Global Photodynamic Therapy market, By End User
    • Hospitals
    • Clinics
    • Ambulatory Surgical Centers
    • Research Institutes
  • Global Photodynamic Therapy market, By Photosensitizer Type
    • Hematoporphyrin Derivative (HpD)
    • Aminolevulinic Acid (ALA)
    • Chlorins
    • Porphyrins
    • Phthalocyanines
  • Global Photodynamic Therapy market, By Application
    • Oncology
    • Dermatology
    • Gastroenterology
    • Gynecology
    • Urology
  • Global Photodynamic Therapy market, By Treatment Type
    • Topical PDT
    • Systemic PDT
    • Local PDT
  • Global Photodynamic Therapy market, By Light Source
    • Laser Light
    • Light Emitting Diodes (LEDs)
  • Global Photodynamic Therapy market, By Patient Type
    • Adult Patients
    • Pediatric Patients
  • Global Photodynamic Therapy market, By Distribution Channel
    • Direct Sales
    • Distributors
  • Global Photodynamic Therapy market, By Region
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Company Profiles
    • Biofrontera AG
    • Theralase Technologies Inc.
    • Photocure ASA
    • Quest PharmaTech Inc.
    • Galderma S.A.
    • DUSA Pharmaceuticals (a subsidiary of Sun Pharmaceutical Industries)
    • Lumenis Ltd. (acquired by Bausch Health Companies Inc.)
    • Biolitec AG
    • IPG Photonics Corporation
    • Boston Scientific Corporation
    • Asieris Meditech Co., Ltd.
    • PDT Pharmaceuticals, Inc.
    • Candela Corporation (a subsidiary of Syneron Medical Ltd.)
    • Biolase, Inc.
    • Photothera (now known as EpiCept Corporation)

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Photodynamic Therapy, By Product Type
    • Market Photodynamic Therapy, By Light Source
    • Market Photodynamic Therapy, By Application
    • Market Photodynamic Therapy, By End User
    • Market Photodynamic Therapy, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
  • Increasing incidence of cancer and skin disorders
  • Demand for minimally invasive treatment Advancements in technology
    • Restraints
  • High treatment costs
  • Complex treatment protocols
    • Opportunities
  • Personalized treatment approaches
  • Collaboration with pharmaceutical companies
  • Advancements in imaging techniques
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Photodynamic Therapy Market- Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Photodynamic Therapy Market, By Product Type, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Photosensitizer Drugs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Porphyrin Derivative (PD)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Hematoporphyrin Derivative (HpD)
  • Benzoporphyrin Derivative (BPD)
  • Texaphyrins
  • Others
  • Aminolevulinic acid (ALA)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Chlorins
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Photodynamic Therapy Devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Disposable Fiber Optic Light Delivery Devices (DFOLDD)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Diode Laser
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

6. Global Photodynamic Therapy Market, By Light Source, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Lasers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Light Emitting Diodes (LEDs)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Lamps
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

7. Global Photodynamic Therapy Market, By Application, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Actinic Keratosis (AK)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Psoriasis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Acne
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

8. Global Photodynamic Therapy Market, By End User, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Cancer Treatment Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Cosmetic and Dermatology Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032 ,(US$ Bn )

9. Global Photodynamic Therapy Market, By Region, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2021 -2032
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Light Source, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Light Source, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Light Source, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Light Source, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Light Source, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Light Source, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Bn)

10. Competitive Landscape

  • Gladerma S.A.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Sun Pharmaceutical Industries Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Biofrontera
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Novartis AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Valeant Pharmaceuticals International, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Quest Pharmatech, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Hologic, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Lumibird (Quantel Medical)
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Theralase Technologies Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Photocure ASA
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Biolitec AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • IPG Photonics Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

11. Section

  • Research Methodology
  • About us